Group One Trading
INO icon

Group One Trading’s Inovio Pharmaceuticals INO Stock Holding History

Group One Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,924
Closed -$5.6K – 8258
2025
Q1 		$4.77K Sell
2,924
-9,446
-76% -$19K ﹤0.01% 6666
2024
Q4 		$22.6K Sell
12,370
-4,540
-27% -$20.1K ﹤0.01% 5608
2024
Q3 		$97.7K Buy
16,910
+1,339
+9% +$11K ﹤0.01% 4200
2024
Q2 		$126K Buy
15,571
+120
+0.8% +$1.26K ﹤0.01% 3777
2024
Q1 		$214K Buy
15,451
+11,754
+318% +$101K ﹤0.01% 3509
2023
Q4 		$22.6K Buy
3,697
+1,022
+38% +$5.04K ﹤0.01% 5651
2023
Q3 		$12.5K Sell
2,675
-622
-19% -$3.44K ﹤0.01% 6212
2023
Q2 		$17.7K Sell
3,297
-408
-11% -$3.29K ﹤0.01% 6065
2023
Q1 		$36.5K Buy
+3,705
New +$63.2K ﹤0.01% 5085
2022
Q4 		– Sell
-99
Closed -$2.24K – 7641
2022
Q3 		$2K Buy
+99
New +$2.54K ﹤0.01% 7159
2022
Q2 		– Sell
-15,664
Closed -$441K – 8129
2022
Q1 		$675K Buy
15,664
+15,256
+3,739% +$687K ﹤0.01% 3492
2021
Q4 		$24K Buy
+408
New +$32.7K ﹤0.01% 6866
2019
Q4 		– Sell
-484
Closed -$14.6K – 5329
2019
Q3 		$12K Sell
484
-1,266
-72% -$38.5K ﹤0.01% 4539
2019
Q2 		$62K Sell
1,750
-525
-23% -$20.9K ﹤0.01% 3656
2019
Q1 		$102K Buy
2,275
+1,581
+228% +$79.7K ﹤0.01% 3159
2018
Q4 		$33K Buy
694
+241
+53% +$14.6K ﹤0.01% 3763
2018
Q3 		$30K Sell
453
-557
-55% -$31K ﹤0.01% 4229
2018
Q2 		$48K Sell
1,010
-3,064
-75% -$169K ﹤0.01% 3981
2018
Q1 		$230K Buy
4,074
+3,844
+1,671% +$208K ﹤0.01% 2681
2017
Q4 		$11K Buy
+230
New +$14.3K ﹤0.01% 4351
2017
Q3 		– Sell
-1,882
Closed -$140K – 4973
2017
Q2 		$177K Buy
+1,882
New +$161K ﹤0.01% 2727
2017
Q1 		– Sell
-765
Closed -$61K – 4797
2016
Q4 		$64K Buy
+765
New +$69.2K ﹤0.01% 3106
2016
Q1 		– Sell
-11,051
Closed -$853K – 4737
2015
Q4 		$891K Sell
11,051
-399
-3% -$31.8K 0.01% 1383
2015
Q3 		$794K Buy
11,450
+831
+8% +$72.4K 0.01% 1418
2015
Q2 		$1.04M Buy
10,619
+6,969
+191% +$745K 0.01% 1172
2015
Q1 		$357K Buy
3,650
+124
+4% +$12K 0.01% 1887
2014
Q4 		$388K Sell
3,526
-1,159
-25% -$142K 0.01% 1755
2014
Q3 		$554K Buy
4,685
+426
+10% +$53.1K 0.01% 1541
2014
Q2 		$552K Buy
4,259
+3,407
+400% +$402K 0.01% 1563
2014
Q1 		$136K Buy
+852
New +$122K ﹤0.01% 2773

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's INO Position: Q2 2025 in Review

Group One Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 2,924 shares — an estimated $5.6K sold.

Group One Trading first reported a position in INO in Q1 2014 and held it in 30 quarters. The position peaked at $1.04M in Q2 2015. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Group One Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 2,924 Inovio Pharmaceuticals shares in Q2 2025, an estimated $5.6K.
  • Group One Trading first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 30 quarters.
  • Group One Trading's Inovio Pharmaceuticals position peaked at $1.04M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.